[Antibiotic prophylaxis in laterobasal fractures]

K Steidtmann1, A Welge-Lüssen, R Probst

  • 1HNO-Universitätsklinik Basel.

HNO
|June 1, 1997
PubMed

Insights

Prophylactic antibiotics do not significantly reduce meningitis risk in lateral skull base fractures. Early detection and treatment of meningitis symptoms are recommended over preventative antibiotic use.

Area of Science:

  • Neurosurgery
  • Infectious Disease

Background:

  • Lateral skull base fractures are serious injuries.
  • Meningitis is a potential complication.

Purpose of the Study:

  • To determine if antibiotic prophylaxis reduces meningitis risk in patients with lateral skull base fractures.

Main Methods:

  • Retrospective study of 78 patients over 5 years.
  • Evaluation of medical records for antibiotic use and meningitis development.

Main Results:

  • No significant difference in meningitis rates between patients who received prophylactic antibiotics and those who did not.
  • Meningitis occurred in 4/55 (7.3%) patients without antibiotics vs. 2/22 (9.1%) with antibiotics.
  • In patients with otoliquorrhea, 0/6 (0%) without antibiotics developed meningitis vs. 2/8 (25%) with antibiotics.

Conclusions:

  • Prophylactic antibiotics are not advisable for lateral skull base fractures.
  • Frequent monitoring and prompt treatment of meningitis symptoms are recommended.

Related Concept Videos

Fractures: Bone Repair01:27

Fractures: Bone Repair

Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the procedure...
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Epistaxis01:30

Epistaxis

Epistaxis, or nosebleeds, occurs when small, swollen blood vessels in the nasal mucous membrane rupture. Typically, the anterior septum is the primary site of occurrence.
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...